NovixaNOVIXA
Registrati gratis

📄 Articolo condiviso da Novixa

Studio di coorte

Accettazione dell'antibody monoclonale contro il virus respiratorio sinciziale dell'infanzia nirsevimab tra donne post-partum in Italia.

Angelillo S, Miraglia Del Giudice G, Della Polla G, Angelillo IF

Human vaccines & immunotherapeutics·1 giugno 2026·DOI ↗

The purposes of the cross-sectional survey were to investigate among a sample of post-partum women in Italy the attitudes and the behaviors about the respiratory syncytial virus (RSV) infant monoclonal antibody and to explore any associations with different characteristics.The survey was conducted between March and April 2025 in teaching and public hospitals randomly selected in Southern Italy. The data were collected using a structured questionnaire through a face-to-face interview for those women in the maternity wards and by telephone for those who were at home.A total of 476 women completed the interview for a response rate of 96.6%. Half (50.8%) reported that the monoclonal antibody was

Analisi completa · 5 minuti

🔒 Metodologia, numeri e implicazioni pratiche

Disponibile gratis registrandoti su Novixa.

Leggi l'analisi completa →

Aggiornati come fanno i migliori medici

Ogni sera le novità scientifiche della tua specializzazione, sintetizzate nella tua lingua. 14 giorni di Pro gratis.

Inizia gratis